What is NDC 82009-197?

82009-197 is the product NDC for Dasatinib, Dasatinib 140 mg/1 tablet, film coated, listed with the FDA by Quallent Pharmaceuticals Health LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Quallent Pharmaceuticals Health LLC, NDC labeler code 82009. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dasatinib?

95 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dasatinib NDC 82009-197 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)82009-197Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82009-0197Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82009-197-30	8200901973082009019730	30 TABLET, FILM COATED in 1 BOTTLE (82009-197-30)Marketed from Nov 2, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dasatinib
Generic name (nonproprietary): dasatinib
Active ingredients: Dasatinib — 140 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Quallent Pharmaceuticals Health LLCNDC labeler code 82009
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217217
Marketing start: Nov 2, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 3A4 Inhibitors (Mechanism)Protein Kinase Inhibitors (Mechanism)
Identifiers: Product ID 82009-197_669a5206-88e3-1014-a561-aa33f2b7b3a7SPL ID 669a5206-88e3-1014-a561-aa33f2b7b3a7
Pharmacologic class: Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482009019730 followed by a unit qualifier and the quantity

Package 82009-0197-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 82009-197

What is NDC 82009-197?: 82009-197 is the product NDC for Dasatinib, Dasatinib 140 mg/1 tablet, film coated, listed with the FDA by Quallent Pharmaceuticals Health LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dasatinib.
What is the active ingredient?: Dasatinib.
Who is the labeler?: Quallent Pharmaceuticals Health LLC, NDC labeler code 82009. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dasatinib?: 95 other product NDCs are listed under this name. See all Dasatinib NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dasatinib NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dasatinib	Dasatinib 20 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-192	82009-0192-60
Dasatinib	Dasatinib 100 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-196	82009-0196-30
Dasatinib	Dasatinib 50 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-193	82009-0193-60
Dasatinib	Dasatinib 70 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-194	82009-0194-60
Dasatinib	Dasatinib 80 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-195	82009-0195-30
Dasatinib	Dasatinib 20 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-319	72205-0319-60
Dasatinib	Dasatinib 100 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-323	72205-0323-30
Dasatinib	Dasatinib 50 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-320	72205-0320-60
Dasatinib	Dasatinib 70 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-321	72205-0321-60
Dasatinib	Dasatinib 80 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-322	72205-0322-30

All 96 Dasatinib NDCs

Other NDCs under ANDA 217217

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217217
Product	Strength	Form · route	Labeler	Product NDC
Dasatinib	Dasatinib 20 mg/1	Tablet, Film coatedOral	BluePoint Laboratories	68001-660
Dasatinib	Dasatinib 50 mg/1	Tablet, Film coatedOral	BluePoint Laboratories	68001-661
Dasatinib	Dasatinib 70 mg/1	Tablet, Film coatedOral	BluePoint Laboratories	68001-662
Dasatinib	Dasatinib 80 mg/1	Tablet, Film coatedOral	BluePoint Laboratories	68001-663
Dasatinib	Dasatinib 100 mg/1	Tablet, Film coatedOral	BluePoint Laboratories	68001-664
Dasatinib	Dasatinib 140 mg/1	Tablet, Film coatedOral	BluePoint Laboratories	68001-665
Dasatinib	Dasatinib 20 mg/1	Tablet, Film coatedOral	Biocon Pharma Inc.	70377-083
Dasatinib	Dasatinib 50 mg/1	Tablet, Film coatedOral	Biocon Pharma Inc.	70377-084
Dasatinib	Dasatinib 70 mg/1	Tablet, Film coatedOral	Biocon Pharma Inc.	70377-085
Dasatinib	Dasatinib 80 mg/1	Tablet, Film coatedOral	Biocon Pharma Inc.	70377-086
Dasatinib	Dasatinib 100 mg/1	Tablet, Film coatedOral	Biocon Pharma Inc.	70377-087
Dasatinib	Dasatinib 140 mg/1	Tablet, Film coatedOral	Biocon Pharma Inc.	70377-088